On 11 Mar 2015
Ahead of the first ESCP/ECCO regional masterclass in Moscow, Professor Yves Panis (Professor of Digestive Surgery at the Université Paris VII and Head of the Department of Colorectal Surgery at Beaujon Hospital, Clichy, France) discusses the surgical treatment of acute severe colitis. Although there are no established national registries or surveys on the exact numbers regarding the prevalence of acute severe colitis, the current evidence suggests that around 10-15% of all the patients with ulcerative colitis will at some point develop acute severe colitis. Although which patients will develop the condition and why, is unknown.
On 4 Mar 2015
The ESCP, in conjunction with the European Crohn's and Colitis Organisation (ECCO), will hold the first ESCP masterclass in April 2015, in Moscow, Russia. In this exclusive interview, ESCP President, Professor Yury Shelygin, outlines the aims of the course and stresses the importance of the multi-disciplinary team approach when treating ulcerative colitis and Crohn's disease.
On 19 Nov 2014
ESCP is delighted to announce its first regional educational masterclass Moscow, Russia, 16 April 2015, organised in conjunction with S-ECCO. This masterclass will take place on the first day of the International Congress of the Russian Association of Coloproctology meeting (16-18 April 2015) and is organised with the kind agreement and support of Professor Yury Shelygin, President of ESCP, and local organiser.On 20 Oct 2014
This year UEG has a new interactive platform to enhance your congress experience. To follow 100 sessions via livestream and post questions directly to the podium from anywhere in the world, go to live.ueg.eu/week.
On 23 Sep 2014
Professor Andre D’Hoore, who chaired both the Guidelines Synthesis report session and the keynote lecture by Evaghelos Xynos, talked with us about rectal prolapse before our annual meeting in Barcelona… “There is a lot of debate on how to manage perianal Crohn’s disease. A recent publication in Gut on a ‘global consensus’ on classification, diagnosis and multidisciplinary treatment demonstrates the shortage of high quality randomised clinical trials for surgical options for patients with Crohn’s disease,” began Professor D’Hoore.ESCP Secretariat
c/o MCI UK Ltd
Unit 24/22 South
Building 4000, Langstone Park
Langstone Road
Havant PO9 1SA
01730 715 208
